Pharmacokinetics of intravenous erythromycin

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Drug Metabolism

Background:

• Erythromycin is a widely used antibiotic.
• Understanding its pharmacokinetic profile is crucial for effective dosing.

Purpose of the Study:

• To investigate the pharmacokinetics of erythromycin after intravenous administration.
• To assess the impact of renal function on erythromycin's elimination half-life.

Main Methods:

• Intravenous infusion of erythromycin in male subjects.
• Serum concentration monitoring over time.
• Pharmacokinetic analysis using a two-compartment model.

Main Results:

• Erythromycin's serum half-life was 2 hours in subjects with normal renal function.
• Half-life increased to 3.9 and 7.0 hours in subjects with severe renal impairment.
• Two-compartment model adequately described postinfusion serum levels.

Conclusions:

• Renal function significantly influences erythromycin's elimination half-life.
• Distribution volume estimates can aid in calculating oral absorption efficiency.